Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
252 people get CSII articles and Market Currents by email alert.
Get email alerts on CSII »
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
Business Wire (May 1, 2013)
-
Business Wire (Apr 24, 2013)
-
Business Wire (Mar 20, 2013)
-
Business Wire (Mar 19, 2013)
-
Business Wire (Mar 15, 2013)
-
Business Wire (Mar 12, 2013)
-
Business Wire (Mar 11, 2013)
-
Business Wire (Feb 25, 2013)
-
Business Wire (Feb 19, 2013)
-
Business Wire (Jan 30, 2013)
-
Business Wire (Jan 25, 2013)
-
Business Wire (Jan 23, 2013)
-
Business Wire (Jan 16, 2013)
-
Business Wire (Nov 27, 2012)
-
Business Wire (Nov 6, 2012)
-
Lee Ainslie's Maverick Capital Sells Cardiovascular Systems WarrantsMarket Folly • Fri, Dec 3, 2010
-
Maverick Issues Correction on Cardiovascular Systems HoldingMarket Folly • Fri, Apr 3, 2009
-
Maverick Capital Files 13G for Cardiovascular SystemsMarket Folly • Tue, Mar 17, 2009
-
Top Medtech Analyst Points To Post-Obamacare OpportunitiesLife Sciences Report • Thu, Sep 6, 2012
-
Spectranetics Still Searching For Traction In PeripheralStephen Simpson • Tue, Feb 21, 2012
-
PAD Awareness Month Brings Cardiovascular Companies to the ForefrontDouglas Cress • Thu, Sep 16, 2010
-
Big Lineup of Healthcare Stocks Crack the Russell 3000 IndexM. E. Garza • Wed, Jul 1, 2009
-
Business Wire (May 1, 2013)
-
Business Wire (Apr 24, 2013)
-
Business Wire (Mar 20, 2013)
-
Business Wire (Mar 19, 2013)
-
Business Wire (Mar 15, 2013)
-
Business Wire (Mar 12, 2013)
-
Business Wire (Mar 11, 2013)
-
Business Wire (Feb 25, 2013)
-
Business Wire (Feb 19, 2013)
-
Business Wire (Jan 30, 2013)
-
Business Wire (Jan 25, 2013)
-
Business Wire (Jan 23, 2013)
-
Business Wire (Jan 16, 2013)
-
Business Wire (Nov 27, 2012)
-
Business Wire (Nov 6, 2012)
-
Business Wire (Oct 30, 2012)
-
Business Wire (Oct 23, 2012)
-
Business Wire (Oct 17, 2012)
CSII vs. ETF Alternatives
Company Description
Currently, there's no company description for CSII.
- All
- | Earnings
- | Dividends
- | M&A
- | On the move
- Thursday, May 2, 6:26 AM Cardiovascular Systems (CSII): Q1 EPS of -$0.29 beats by $0.03. Revenue of $26.5M beats by $0.5M. (PR) Comment! [Earnings, Breaking News, Healthcare]
- Thursday, January 31, 3:42 PM Cardiovascular Systems (CSII +15%) gains today after reporting a better-than-expected Q2 net loss of $0.28 per share, $0.05 wider than a year ago but nonetheless beating analyst expectations. Revenue climbed 28% Y/Y, as conversions to the company's Stealth 360 treatment for peripheral artery disease continued at a high rate, representing 93% of total device revenues for the quarter. Revenue from office-based labs also climbed at a double-digit pace. Comment! [Healthcare, On the Move, Earnings]
- Thursday, January 31, 4:38 AM Cardiovascular Systems (CSII): FQ2 EPS of -$0.28 beats by $0.03. (PR) Comment! [Earnings, Breaking News, On the Move]
LATEST REPLIES

